KK
AMLX icon

KLP Kapitalforvaltning’s Amylyx Pharmaceuticals AMLX Stock Holding History

KLP Kapitalforvaltning’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$242K Hold
17,400
– – ﹤0.01% 1746
2025
Q4 		$210K Buy
+17,400
New +$236K ﹤0.01% 1821

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

KLP Kapitalforvaltning's AMLX Position: Q1 2026 in Review

KLP Kapitalforvaltning held its Amylyx Pharmaceuticals (AMLX) position steady in Q1 2026 at 17,400 shares worth $242K. The position accounts for ﹤0.01% of the portfolio, ranked #1746.

KLP Kapitalforvaltning first reported a position in AMLX in Q4 2025 and has held it in 2 quarters since. 171 funds tracked by Wall St. Rank hold AMLX as of Q1 2026.

  • KLP Kapitalforvaltning held 17,400 shares of Amylyx Pharmaceuticals worth $242K as of Q1 2026.
  • KLP Kapitalforvaltning left its Amylyx Pharmaceuticals share count unchanged in Q1 2026.
  • Amylyx Pharmaceuticals made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q1 2026, its #1746 holding.
  • KLP Kapitalforvaltning first reported a position in Amylyx Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 171 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.